Phosphatidylinositol 4

Phosphatidylinositol 4 Uses, Dosage, Side Effects, Food Interaction and all others data.

Phosphatidylinositol 4 is under investigation in clinical trial NCT02957266 (Cervical Cancer Radiotherapy by Use of VMAT, Individualized Polyradiosensitization and Interstitial Brachytherapy).

Trade Name Phosphatidylinositol 4
Generic PIK3CA
PIK3CA Other Names Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform, PIK3CA
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Phosphatidylinositol 4
Phosphatidylinositol 4

Innovators Monograph

You find simplified version here Phosphatidylinositol 4

*** Taking medicines without doctor's advice can cause long-term problems.
Share